Elafibranor and its Impurities

Elafibranor brand name - Iqirvo is a novel oral medication approved for the treatment of primary biliary cholangitis (PBC), a chronic autoimmune liver disease. Reference standards of Elafibranor API, and its pharmacopeial, non pharmacopeial impurities, and stable isotopes are listed below.